BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25385459)

  • 1. Prostate cancer: Better use of bone scans in prostate cancer.
    Larson SM
    Nat Rev Urol; 2015 Apr; 12(4):190-1. PubMed ID: 25385459
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study between acid phosphatases and bone gammagraphy in cancer of the prostate].
    González Martín M; Lancina Martín A; Chantada Abal V; Lamas Meilán AC; Miguez Codesido M; Serrano Barrientos J
    Actas Urol Esp; 1985; 9(1):83-8. PubMed ID: 4013851
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer: Bone Scan Index made easy, at last.
    Tombal B
    Nat Rev Urol; 2012 Apr; 9(5):245-6. PubMed ID: 22525142
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate-specific antigen level and risk of bone metastasis in Sudanese patients with prostate cancer.
    Khalid KE; Brair AI; Elhaj AM; Ali KE
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1041-3. PubMed ID: 21912047
    [No Abstract]   [Full Text] [Related]  

  • 5. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
    Anand A; Morris MJ; Kaboteh R; Båth L; Sadik M; Gjertsson P; Lomsky M; Edenbrandt L; Minarik D; Bjartell A
    J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI or bone scan or both for staging of prostate cancer?
    Venkitaraman R; Sohaib A; Cook G
    J Clin Oncol; 2007 Dec; 25(36):5837-8; author reply 5838-9. PubMed ID: 18089886
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tumor markers in cancer of the prostate].
    Nogueira March JL; Ojea A; Jamardo D; Figueiredo L; Diez E; Pérez Villanueva J
    Actas Urol Esp; 1985; 9(1):79-82. PubMed ID: 4013850
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative evaluation of bone scanning, histological and biological studies of bone marrow in the staging of prostate cancer].
    Aguirre F; Díaz González R; Leiva O; Mayor J; Borobia V
    Actas Urol Esp; 1981; 5(2):99-104. PubMed ID: 7270287
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate-specific antigen and the bone scan.
    Nunan TO; O'Doherty M
    Nucl Med Commun; 1992 Aug; 13(8):579. PubMed ID: 1381068
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation between bone metabolic markers and bone scan in prostatic cancer.
    Maeda H; Koizumi M; Yoshimura K; Yamauchi T; Kawai T; Ogata E
    J Urol; 1997 Feb; 157(2):539-43. PubMed ID: 8996351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between pretreatment serum levels of prostate specific antigen and bone metastasis in prostate cancer].
    Kageyama Y; Kihara K; Kamata S; Nagahama K; Yonese J; Fukuda H; Tosaka A; Nagamatsu H; Ishizaka K; Tsujii T; Kitahara S; Morita T; Oshima H
    Hinyokika Kiyo; 1996 Mar; 42(3):197-9. PubMed ID: 8619388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of bone gammagraphy and pain in the follow-up of carcinoma of the prostate].
    Ruiz Cerdá JL; Llopis Minguez B; Server Pastor G; Vidal Moreno JF; Boronat Tormo F; Jiménez Cruz JF
    Arch Esp Urol; 1989; 42 Suppl 2():206-8. PubMed ID: 2639624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can we do without bone gammagraphy in the staging of prostatic cancer?].
    Morote J; Olona M; Villa J; Reig C; López MA; de Torres JA; Soler A
    Actas Urol Esp; 1992 Jun; 16(6):487-9; discussion 489-90. PubMed ID: 1509919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the royal marsden hospital.
    Thurairaja R; Barrass B; McFarlane JP; Persad R
    BJU Int; 2004 Jun; 93(9):1358-9. PubMed ID: 15180642
    [No Abstract]   [Full Text] [Related]  

  • 15. Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital.
    Sandblom G; Varenhorst E
    BJU Int; 2004 Apr; 93(6):889-90. PubMed ID: 15050020
    [No Abstract]   [Full Text] [Related]  

  • 16. An assessment of bone scans for monitoring osseous metastases in patients being treated for prostate carcinoma.
    Slack NH; Karr JP; Chu TM; Murphy GP
    Prostate; 1980; 1(2):259-70. PubMed ID: 15619925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone scan in initial staging of prostate cancer.
    Boughattas S; Letaief B; Hassine H; Chatti K; Essabah H
    Tunis Med; 2003 Jun; 81(6):400-6. PubMed ID: 14534946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are bone scans necessary in men with low prostate specific antigen levels following localized therapy?
    Warren KS; Chodak GW; See WA; Iverson P; McLeod D; Wirth M; Morris C; Armstrong J
    J Urol; 2006 Jul; 176(1):70-3; discussion 73-4. PubMed ID: 16753371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography.
    Hayward SJ; McIvor J; Burdge AH; Jewkes RF; Williams G
    Br J Radiol; 1987 Jan; 60(709):79-81. PubMed ID: 3814999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone scintigraphy for diagnosis of bone metastasis in patients with prostatic cancer].
    Nakashima J
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():135-9. PubMed ID: 12599559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.